Evaluate the Safety, Tolerability, Pharmacokinetics,and Clinical Activity of FB704A
Clinical trial NCT03890302 · COMPLETED
Trial details
- NCT number
- NCT03890302
- Sponsor
- Fountain Biopharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-14
- Primary completion
- 2020-05-27
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.